
|Articles|June 24, 2009
Gene therapies
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma.
Advertisement
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma. In the Survey of Ophthalmology (Vol 54, No 4) Xuyanf Lie et al., look at Gene Therapy Targeting Glaucoma: Where Are We? and concludes: "Improvements in gene delivery techniques, refinement of vector construction methods, and development of better animal models combine to bring this potential therapy closer to reality."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Beyond anti-VEGF: The next wave in retinal therapy
2
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
3
Trehalose-hyaluronate combination aids tear film after eyelid surgery
4
ZEISS reports early implantations of AT LUCIA Toric 721P IOL in Europe
5




















